Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Outcome

Indrayani Biotech Board Meeting Outcome

Indrayani Biotech's board approved exploring the demerger of its food division into a separate company and constituted a 'Restructuring Committee' for evaluation. Additionally, M/S Vaithianathan & Associates was appointed as Internal Auditor for FY 2025-26 and 2026-27.

Source

BSE filing, NSE: INDRANIB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Indrayani Biotech Ltd: key numbers

Share price
₹7.81
Market cap
₹41.91 Cr
Revenue (annual)
₹137.8 Cr
Net profit (annual)
₹2.16 Cr
P/E (TTM)
20.0×Sector 27.1×
Promoter holding
32.92%-0.34% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Indrayani Biotech Ltd

All →

Other board meeting outcome announcements

All →